Paul McBarron files SEC Form 4 disclosures for Cyclacel Pharmaceuticals, Inc.. They have made 4 open-market trades across 1 company since 2008, most recently 2023-12-21.
CIK 0001357397
4 open-market purchases totalling $56K since 2008, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CYCC | 33,378 | $212K |
Shares reported on the most recent Form 4, priced at the 2023-12-26 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.